ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 69 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $5,923,000 | -58.0% | 2,575,000 | -19.9% | 0.15% | -58.9% |
Q2 2021 | $14,116,000 | -39.5% | 3,215,434 | 0.0% | 0.36% | -48.5% |
Q1 2021 | $23,344,000 | +203.7% | 3,215,434 | +71.9% | 0.70% | +102.0% |
Q3 2020 | $7,686,000 | -22.4% | 1,870,000 | +13.3% | 0.34% | -41.3% |
Q2 2020 | $9,900,000 | +34.8% | 1,650,000 | +69.2% | 0.59% | -24.8% |
Q1 2020 | $7,342,000 | -34.9% | 975,000 | +18.9% | 0.78% | -24.9% |
Q4 2019 | $11,275,000 | -99.7% | 820,000 | +164.5% | 1.04% | +172.2% |
Q3 2019 | $3,682,800,000 | +163.2% | 310,000 | +210.0% | 0.38% | +190.8% |
Q2 2019 | $1,399,000,000 | – | 100,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |